PROX1 and glioma: Although still consistent with the histopathological diagnosis of WHO grade II glioma, such tumours displaying a high proportion of PROX1-positive cells may be further advanced on the evolution to anaplastic gliomas compared with tumours with few PROX1 expressing tumour cells.